Reproduction

Displaying 1 - 10 of 40 items.

Ernst Gräfenberg (1881–1957)

By Baylee A. Edwards

Ernst Gräfenberg was a physician and researcher who studied sexology, the study of human sexuality, in both Germany and the United States during the first half of the twentieth century. Gräfenberg researched the use of intrauterine devices as a form of contraception, and he developed the Gräfenberg ring. The Gräfenberg ring was one of the first intrauterine devices that effectively prevented pregnancy without causing infection, and it became the forerunner of all modern intrauterine devices, or IUDs. Gräfenberg also studied the role of the urethra in female orgasm.

Format: Articles

Subject: People, Technologies, Reproduction

NuvaRing

By Molly Jacobson

The NuvaRing is a self-administered hormonal contraceptive device in the form of a flexible plastic ring that is inserted into the vagina. It releases the hormones etonogestrel and ethinylestradiol, which are synthetic forms of the female reproductive hormones progesterone and estrogen, respectively. The pharmaceutical company Organon first made NuvaRing in the Netherlands in 1980s. The Netherlands first approved it for use in February of 2001, and the United States did the same in October of that year.

Format: Articles

Subject: Technologies, Reproduction, Legal

“Cardiovascular Risk Associated With the Use of an Etonogestrel-Containing Vaginal Ring” (2013), by Jürgen Dinger, Sabine Möhner, and Klaas Heinemann

By Molly Jacobson

In October 2013, Jürgen Dinger, Sabine Möhner, and Klaas Heinemann published the article “Cardiovascular Risk Associated With the Use of an Etonogestrel-Containing Vaginal Ring,” hereafter “Cardiovascular Risk,” in the journal Obstetrics and Gynecology. The authors enrolled patients in the study who were new users of either a vaginal contraceptive ring known as NuvaRing or a combined oral contraceptive pill. A combined oral contraceptive pill contains a formulation of the hormones progesterone and estrogen.

Format: Articles

Subject: Technologies, Reproduction

Microsurgical Vasovasostomy

By Cole Nichols

Vasovasostomy is a microsurgical procedure to restore fertility after vasectomy, a surgery that sterilizes the patient by severing the vas deferentia, the tubes that carry the sperm from the testes to the penis. After a vasectomy, a patient may have various reasons for wanting to reverse the procedure, such as new opportunities for having children or a new romantic partnership. A vasovasostomy involves reestablishing the flow of sperm through the vas deferens by reconnecting the severed ends of the tube. In 1919, in the United States, William C.

Format: Articles

Subject: Technologies, Reproduction

No-scalpel Vasectomy

By Cole Nichols

No-scalpel vasectomy, or NSV or keyhole vasectomy, is a surgical method of sterilization that involves puncturing the skin of the scrotum to access the vas deferens, a tube that carries spermatozoa, or sperm, from the testes to the penis. The surgeon performing the procedure blocks the flow of sperm through the vas deferens, sterilizing the patient. NSV is a less invasive procedure, as it does not use a scalpel to make a deep cut on sensitive scrotal tissue.

Format: Articles

Subject: Technologies, People, Organizations, Places, Reproduction

Phalloplasty

By Riley McInnis

Phalloplasty is a type of surgery that takes existing skin, tissue, and nerves from surrounding areas on a patient’s body to repair or form a neophallus, or a new penis structure. In 1946, Harold Gillies, a plastic surgeon who practiced in England, performed one of the first modern phalloplasties that entailed creating an entire neophallus for a transsexual, called transgender as of 2022, man in London, England. The reconstructive need for phalloplasties started as a result of treating blast wounds during World War I and World War II.

Format: Articles

Subject: Technologies, Reproduction

Edwin Carlyle (Carl) Wood (1929–2011)

By Whitney Alexandra Tuoti

Edwin Carlyle Wood, also known as Carl Wood, was a physician who helped develop in vitro fertilization, or IVF, treatments. From 1964 to 1992, Wood worked as a professor of obstetrics and gynecology at Monash University in Melbourne, Australia, where he was one of the first in the world to lead a team of physicians to establish IVF as a proven treatment for infertility. IVF refers to a medical procedure in which scientists inseminate an egg cell with a sperm cell outside of the body, such as in a glass dish in a clinical setting.

Format: Articles

Subject: People, Technologies, Reproduction

Transvaginal Ultrasound-Guided Oocyte Retrieval

By Alison Lane

Transvaginal ultrasound-guided oocyte retrieval, also known as egg retrieval, is a surgical technique used by medical professionals to extract mature eggs directly from the women’s ovaries under the guidance of ultrasound imaging. In 1982, physicians Suzan Lenz and Jorgen Lauritsen at the University of Copenhagen in Copenhagen, Denmark, proposed the technology to improve the egg collection aspect of in vitro fertilization, or IVF. During IVF, a healthcare practitioner must remove mature eggs from a woman’s ovaries to fertilize them with sperm outside of the body.

Format: Articles

Subject: Technologies, Reproduction

Oral Glucose Tolerance Test for Gestational Diabetes

By Alison Lane

In the twentieth century, researchers developed the oral glucose tolerance test, or OGTT, as a method to diagnose different types of diabetes, a medical condition that causes blood sugar levels to become abnormally high. During the test, a healthcare provider measures a person’s blood sugar levels before and after the person consumes a predetermined amount of glucose solution. While not exclusively used for pregnant women, an OGTT may test for gestational diabetes which, according to the International Diabetes Federation, affected one in six pregnancies worldwide in 2019.

Format: Articles

Subject: Technologies, Reproduction, Experiments

Recombinant Gonadotropins Used in Fertility Treatments

By Alison Lane

First manufactured in 1988 by Serono laboratories, recombinant gonadotropins are synthetic hormones that can stimulate egg production in women for use in fertility treatments. Recombinant gonadotropins are artificially created using recombinant DNA technology, a technology that joins together DNA from different organisms. In vertebrates, naturally-occurring gonadotropins regulate the growth and function of the gonads, known as testes in males and ovaries in females.

Format: Articles

Subject: Technologies, Reproduction

Pages